मंगलवार, 14 मई 2019

CinCor Pharma In-Licenses Aldosterone Synthase Inhibitor, CIN-107, and Closes $50 Million Series A Financing



from Venture Capital Access Online: Latest Venture Capital and Private Equity News http://bit.ly/2LHuSq2
via IFTTT

लेबल:

0 टिप्पणियाँ:

एक टिप्पणी भेजें

सदस्यता लें टिप्पणियाँ भेजें [Atom]

<< मुख्यपृष्ठ